Equities analysts forecast that Constellium NV (NYSE:CSTM) will post earnings of $0.09 per share for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for Constellium’s earnings. The highest EPS estimate is $0.19 and the lowest is $0.02. Constellium posted earnings of ($0.23) per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 139.1%. The company is scheduled to report its next earnings report on Thursday, February 20th.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.
On average, analysts expect that Constellium will report full year earnings of $0.37 per share for the current year, with EPS estimates ranging from $0.33 to $0.39. For the next fiscal year, analysts forecast that the business will post earnings of $1.06 per share, with EPS estimates ranging from $0.82 to $1.36. Zacks’ EPS calculations are a mean average based on a survey of research analysts that follow Constellium.
Constellium (NYSE:CSTM) last announced its quarterly earnings data on Wednesday, October 23rd. The industrial products company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.27). Constellium had a negative net margin of 0.28% and a negative return on equity of 12.92%. The company had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.45 billion. During the same quarter in the previous year, the business earned $1.54 EPS. The company’s quarterly revenue was up 2.3% compared to the same quarter last year.
A number of equities research analysts recently weighed in on the stock. Credit Suisse Group lifted their price objective on shares of Constellium from $20.00 to $23.00 and gave the company an “outperform” rating in a report on Tuesday, October 15th. ValuEngine lowered shares of Constellium from a “buy” rating to a “hold” rating in a report on Saturday, October 5th.
A number of institutional investors and hedge funds have recently made changes to their positions in CSTM. FMR LLC lifted its holdings in Constellium by 24.9% during the 1st quarter. FMR LLC now owns 4,166,800 shares of the industrial products company’s stock valued at $33,251,000 after buying an additional 829,800 shares in the last quarter. Segantii Capital Management Ltd bought a new stake in shares of Constellium in the 2nd quarter valued at about $502,000. Boussard & Gavaudan Investment Management LLP raised its holdings in shares of Constellium by 6.2% in the 2nd quarter. Boussard & Gavaudan Investment Management LLP now owns 2,800,293 shares of the industrial products company’s stock valued at $28,577,000 after purchasing an additional 163,629 shares in the last quarter. Quantitative Systematic Strategies LLC raised its holdings in shares of Constellium by 50.7% in the 2nd quarter. Quantitative Systematic Strategies LLC now owns 42,934 shares of the industrial products company’s stock valued at $431,000 after purchasing an additional 14,441 shares in the last quarter. Finally, Signaturefd LLC bought a new stake in shares of Constellium in the 2nd quarter valued at about $40,000. Institutional investors own 66.67% of the company’s stock.
CSTM traded up $0.16 on Tuesday, reaching $14.35. 784,743 shares of the company traded hands, compared to its average volume of 1,082,745. Constellium has a one year low of $6.26 and a one year high of $14.79. The firm has a fifty day simple moving average of $13.40 and a two-hundred day simple moving average of $11.23. The company has a market cap of $1.95 billion, a P/E ratio of 20.21 and a beta of 1.75.
Constellium N.V. engages in the design, manufacture, and sale of specialty rolled and extruded aluminum products for the aerospace, packaging, and automotive end-markets. The company operates in three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.
Featured Article: What causes a stock to be most active?
For more information about research offerings from Zacks Investment Research, visit Zacks.com